Omeros Corp. (OMER)
11.60
-0.04
(-0.34%)
USD |
NASDAQ |
Mar 04, 10:37
Omeros Research and Development Expense (Annual) : 119.52M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Edgewise Therapeutics, Inc. | 149.30M |
| Boston Scientific Corp. | 2.052B |
| Gilead Sciences, Inc. | 5.688B |
| Merck & Co., Inc. | 12.51B |
| REGENXBIO, Inc. | 192.31M |